Suppr超能文献

内源性糖皮质激素对肌肉质量的调节。

The regulation of muscle mass by endogenous glucocorticoids.

机构信息

Department of Internal Medicine, University of Washington Medical Center Seattle, WA, USA ; Papé Family Pediatric Research Institute, Oregon Health and Science University Portland, OR, USA.

Department of Internal Medicine, University of Washington Medical Center Seattle, WA, USA.

出版信息

Front Physiol. 2015 Feb 3;6:12. doi: 10.3389/fphys.2015.00012. eCollection 2015.

Abstract

Glucocorticoids are highly conserved fundamental regulators of energy homeostasis. In response to stress in the form of perceived danger or acute inflammation, glucocorticoids are released from the adrenal gland, rapidly mobilizing energy from carbohydrate, fat and protein stores. In the case of inflammation, mobilized protein is critical for the rapid synthesis of acute phase reactants and an efficient immune response to infection. While adaptive in response to infection, chronic mobilization can lead to a profound depletion of energy stores. Skeletal muscle represents the major body store of protein, and can become substantially atrophied under conditions of chronic inflammation. Glucocorticoids elicit the atrophy of muscle by increasing the rate of protein degradation by the ubiquitin-proteasome system and autophagy lysosome system. Protein synthesis is also suppressed at the level of translational initiation, preventing the production of new myofibrillar protein. Glucocorticoids also antagonize the action of anabolic regulators such as insulin further exacerbating the loss of protein and muscle mass. The loss of muscle mass in the context of chronic disease is a key feature of cachexia and contributes substantially to morbidity and mortality. A growing body of evidence demonstrates that glucocorticoid signaling is a common mediator of wasting, irrespective of the underlying initiator or disease state. This review will highlight fundamental mechanisms of glucocorticoid signaling and detail the mechanisms of glucocorticoid-induced muscle atrophy. Additionally, the evidence for glucocorticoids as a driver of muscle wasting in numerous disease states will be discussed. Given the burden of wasting diseases and the nodal nature of glucocorticoid signaling, effective anti-glucocorticoid therapy would be a valuable clinical tool. Therefore, the progress and potential pitfalls in the development of glucocorticoid antagonists for muscle wasting will be discussed.

摘要

糖皮质激素是能量平衡的高度保守的基本调节剂。在感知到危险或急性炎症的形式的应激下,糖皮质激素从肾上腺释放出来,迅速从碳水化合物、脂肪和蛋白质储存中动员能量。在炎症的情况下,动员的蛋白质对于快速合成急性期反应物和对感染的有效免疫反应至关重要。虽然在感染时是适应性的,但慢性动员会导致能量储存的严重耗竭。骨骼肌是蛋白质的主要身体储存库,在慢性炎症条件下会发生显著萎缩。糖皮质激素通过增加泛素-蛋白酶体系统和自噬溶酶体系统的蛋白质降解率来引起肌肉萎缩。蛋白质合成也在翻译起始水平受到抑制,防止新肌原纤维蛋白的产生。糖皮质激素还拮抗胰岛素等合成代谢调节剂的作用,进一步加剧蛋白质和肌肉质量的丧失。慢性疾病中肌肉质量的丧失是恶病质的一个关键特征,大大增加了发病率和死亡率。越来越多的证据表明,糖皮质激素信号是消耗的共同介导者,无论潜在的启动子或疾病状态如何。这篇综述将重点介绍糖皮质激素信号的基本机制,并详细描述糖皮质激素诱导的肌肉萎缩的机制。此外,还将讨论糖皮质激素作为许多疾病状态下肌肉消耗的驱动因素的证据。鉴于消耗性疾病的负担和糖皮质激素信号的节点性质,有效的抗糖皮质激素治疗将是一种有价值的临床工具。因此,将讨论用于治疗肌肉消耗的糖皮质激素拮抗剂的进展和潜在陷阱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cdf/4315033/249381c1654a/fphys-06-00012-g0001.jpg

相似文献

1
The regulation of muscle mass by endogenous glucocorticoids.
Front Physiol. 2015 Feb 3;6:12. doi: 10.3389/fphys.2015.00012. eCollection 2015.
2
Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease.
Int J Biochem Cell Biol. 2013 Oct;45(10):2245-56. doi: 10.1016/j.biocel.2013.06.015. Epub 2013 Jul 1.
3
Glucocorticoid-induced skeletal muscle atrophy.
Int J Biochem Cell Biol. 2013 Oct;45(10):2163-72. doi: 10.1016/j.biocel.2013.05.036. Epub 2013 Jun 24.
4
Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling.
J Appl Physiol (1985). 2013 May;114(9):1329-39. doi: 10.1152/japplphysiol.00503.2012. Epub 2012 Aug 30.
5
Role of glucocorticoids in the molecular regulation of muscle wasting.
Crit Care Med. 2007 Sep;35(9 Suppl):S602-8. doi: 10.1097/01.CCM.0000279194.11328.77.
7
Mechanisms of glucocorticoid-induced myopathy.
J Endocrinol. 2008 Apr;197(1):1-10. doi: 10.1677/JOE-07-0606.
8
Acute intermittent hypoxia in rats activates muscle proteolytic pathways through a gluccorticoid-dependent mechanism.
J Appl Physiol (1985). 2017 May 1;122(5):1114-1124. doi: 10.1152/japplphysiol.00977.2015. Epub 2016 Dec 8.
9
Autophagic degradation contributes to muscle wasting in cancer cachexia.
Am J Pathol. 2013 Apr;182(4):1367-78. doi: 10.1016/j.ajpath.2012.12.023. Epub 2013 Feb 8.
10
Molecular therapeutic strategies targeting pancreatic cancer induced cachexia.
World J Gastrointest Surg. 2018 Dec 27;10(9):95-106. doi: 10.4240/wjgs.v10.i9.95.

引用本文的文献

1
Cancer Cachexia.
Adv Exp Med Biol. 2025;1478:285-314. doi: 10.1007/978-3-031-88361-3_12.
4
Klf9 Loss of Function Protects Against Glucocorticoids Induced Skeletal Muscle Wasting.
J Cachexia Sarcopenia Muscle. 2025 Aug;16(4):e70020. doi: 10.1002/jcsm.70020.
5
Four Dairy Products Mitigates Sarcopenia in Mice by Modulating Muscle Inflammation, Autophagy, and Protein Degradation.
Food Sci Nutr. 2025 Jul 14;13(7):e70540. doi: 10.1002/fsn3.70540. eCollection 2025 Jul.
7
ZBED6 Knockout Prevents Ageing- and Dexamethasone-Induced Muscle Atrophy via Dkk3 in Pig and Mice.
J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13829. doi: 10.1002/jcsm.13829.
9
The role of irisin in exercise-induced muscle and metabolic health: a narrative review.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 1. doi: 10.1007/s00210-025-04083-1.
10

本文引用的文献

1
TRAF6 inhibition rescues dexamethasone-induced muscle atrophy.
Int J Mol Sci. 2014 Jun 20;15(6):11126-41. doi: 10.3390/ijms150611126.
2
Altered gene expression patterns in muscle ring finger 1 null mice during denervation- and dexamethasone-induced muscle atrophy.
Physiol Genomics. 2013 Dec 1;45(23):1168-85. doi: 10.1152/physiolgenomics.00022.2013. Epub 2013 Oct 15.
3
NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia.
J Clin Invest. 2013 Nov;123(11):4821-35. doi: 10.1172/JCI68523.
4
Glucocorticoid receptor signaling in health and disease.
Trends Pharmacol Sci. 2013 Sep;34(9):518-30. doi: 10.1016/j.tips.2013.07.003. Epub 2013 Aug 14.
5
11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.
Physiol Rev. 2013 Jul;93(3):1139-206. doi: 10.1152/physrev.00020.2012.
6
Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle.
FASEB J. 2013 Sep;27(9):3572-82. doi: 10.1096/fj.13-230375. Epub 2013 Jun 3.
7
Identification of microRNAs involved in dexamethasone-induced muscle atrophy.
Mol Cell Biochem. 2013 Sep;381(1-2):105-13. doi: 10.1007/s11010-013-1692-9. Epub 2013 May 29.
8
PPARβ/δ regulates glucocorticoid- and sepsis-induced FOXO1 activation and muscle wasting.
PLoS One. 2013;8(3):e59726. doi: 10.1371/journal.pone.0059726. Epub 2013 Mar 21.
9
Myostatin suppression of Akirin1 mediates glucocorticoid-induced satellite cell dysfunction.
PLoS One. 2013;8(3):e58554. doi: 10.1371/journal.pone.0058554. Epub 2013 Mar 13.
10
Muscle-specific microRNA1 (miR1) targets heat shock protein 70 (HSP70) during dexamethasone-mediated atrophy.
J Biol Chem. 2013 Mar 1;288(9):6663-78. doi: 10.1074/jbc.M112.390369. Epub 2013 Jan 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验